Trademark: 85768234
Word
LINCODE
Status
Registered
Status Code
702
Status Date
Saturday, May 9, 2020
Serial Number
85768234
Registration Number
4511740
Registration Date
Tuesday, April 8, 2014
Mark Type
4000
Filing Date
Wednesday, October 31, 2012
Published for Opposition
Tuesday, April 9, 2013

Trademark Owner History

Classifications
1 Reagents for use in scientific and medical research, namely: synthetic RNA duplexes for silencing non-coding RNAs in cells
LIN CODE

Trademark Events
Mar 27, 2024
Teas Section 8 & 9 Received
Apr 8, 2023
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
May 9, 2020
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
May 9, 2020
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
May 9, 2020
Case Assigned To Post Registration Paralegal
Mar 18, 2020
Teas Section 8 & 15 Received
Apr 8, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 9, 2018
Automatic Update Of Assignment Of Ownership
Jul 9, 2014
Automatic Update Of Assignment Of Ownership
May 29, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
May 29, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 8, 2014
Registered-Principal Register
Mar 2, 2014
Allowed Principal Register - Sou Accepted
Feb 25, 2014
Statement Of Use Processing Complete
Jan 27, 2014
Use Amendment Filed
Feb 24, 2014
Case Assigned To Intent To Use Paralegal
Jan 27, 2014
Teas Statement Of Use Received
Dec 6, 2013
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2013
Sou Extension 1 Granted
Dec 4, 2013
Sou Extension 1 Filed
Dec 4, 2013
Sou Teas Extension Received
Aug 28, 2013
Automatic Update Of Assignment Of Ownership
Jun 4, 2013
Noa E-Mailed - Sou Required From Applicant
Apr 9, 2013
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2013
Published For Opposition
Mar 20, 2013
Notification Of Notice Of Publication E-Mailed
Feb 27, 2013
Approved For Pub - Principal Register
Feb 27, 2013
Assigned To Examiner
Nov 7, 2012
Notice Of Pseudo Mark Mailed
Nov 6, 2012
New Application Office Supplied Data Entered
Nov 3, 2012
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24